Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




SCCM 2009: High Troponin Levels May Increase Mortality Risk in Noncardiac ICU Patients
Link ID 13188
Title SCCM 2009: High Troponin Levels May Increase Mortality Risk in Noncardiac ICU Patients
Url http://www.medscape.com/viewarticle/587991?src=rss
Description One fifth of noncardiac critically ill patients have high troponin levels; survival odds may increase with beta-blocker treatment. Medscape Medical News
Category Articles > Internal Medicine
Keywords
Date Feb 7, 2009
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Internal Medicine
1. Plasmapheresis for Managing Natalizumab-Associated PML: A Risky Proposition
  These case reports highlight the dilemma faced by clinicians caring for multiple sclerosis patients who develop progressive multifocal leukoencephalopathy during natalizumab treatment. Journal Watch
Category:   Articles > Internal Medicine


2. AAO/SOE 2008: Ranibizumab Appears Safe for Wet Age-Related Macular Degeneration
  Ranibizumab appears safe in the treatment of wet age-related macular degeneration, according to an analysis of 4 large phase 3 trials. Medscape Medical News
Category:   Articles > Internal Medicine


3. Sleep Disturbances and Posttraumatic Stress Disorder
  Quality of life for patients with PTSD may depend in part on quality of sleep. Medscape Pulmonary Medicine
Category:   Articles > Internal Medicine


4. ACOG 2009: Few Trophoblast Cells May Predict Abnormal Pregnancy
  Findings from a small preliminary study indicate that the number of trophoblast cells collected by Pap test in the first trimester of pregnancy can distinguish between normal intrauterine pregnancy and ectopic pregnancy or blighted ovum. Medscape Medical News
Category:   Articles > Internal Medicine


5. Nab-Paclitaxel Improves Progression-Free Survival in Metastatic Breast Cancer
  As first-line therapy for metastatic breast cancer, nab-paclitaxel (Abraxane), a solvent-free formulation of the drug, significantly improves progression-free survival compared with use of docetaxel, researchers report in the Journal of Clinical Oncology for May 26. Reuters Health Information
Category:   Articles > Internal Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS